We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GASS:NASDAQStealthGas, Inc. Analysis

Data as of 2026-09-24 - not real-time

$8.94

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind StealthGas Inc. is bullish at $8.94, with short-term averages leading the long-term ones. Over a rolling month the price has gained 3.4%. With RSI at 41.5 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $8.91 up to resistance at $9.90.
On valuation the read is undervalued — earnings multiple of 5.8 versus a 27.4 sector average, below the peer group. Analyst price targets sit 56.6% above the current price. Revenue is contracting at 9.2% on a 35.0% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 31.1%, a beta of 0.39 and a maximum drawdown of 24.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.

Top Market Events

Fleet downsizing and debt elimination drive 40% profit margins despite lower revenue.On September 2, StealthGas NASDAQ:GASS reported second-quarter revenue of $42.On September 2, StealthGas NASDAQ:GASS reported second-quarter revenue of $42.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 8.78
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 5.8 versus sector average of 27.4
  • Trading above the 200-day average of 8.78

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 5.8 versus sector average of 27.4
  • Analyst targets imply +56.6% versus the current price
  • Profit margin of 35.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-9.20%
Profit Margin34.97%
P/E Ratio5.8
ROE8.54%
ROA4.02%
Debt/Equity0.01
P/B Ratio0.5
Op. Cash Flow$70.8M
Free Cash Flow$-17593384
Industry P/E27.4

Technical Analysis

TrendBullish
RSI41.5
Support$8.91
Resistance$9.90
MA 20$9.35
MA 50$9.14
MA 200$8.78
MACDBearish
VolumeStable
Fear & Greed Index93.45

Valuation

Fair Value$20.42
Target Price$14.00
Upside/Downside56.60%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.39
Volatility31.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.